North America IV Hydration Therapy Market To Reach $2.56 Billion By 2033

North America IV Hydration Therapy Market Growth & Trends

The North America IV hydration therapy market size is expected to reach USD 2.56 billion by 2033, registering a CAGR of 8.6% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer and diabetes is the primary driver of the market. According to the CDC estimates, a significant proportion, specifically 6 in 10 adults in the U.S., grapple with these health challenges, generating a robust demand for effective healthcare solutions. Intravenous (IV) hydration therapy emerges as a critical and efficient intervention, offering a direct and expeditious approach to addressing the consequences and management of chronic diseases. Beyond mere treatment, it becomes a valuable tool that enhances the overall well-being of individuals contending with these persistent health conditions. As the incidence of chronic diseases continues to rise, the market assumes a crucial role, providing specialized care and unwavering support to meet the evolving healthcare needs of the population.

Simultaneously, the prevalence of foodborne illnesses in the North American region presents substantial health challenges, as per CDC estimates. Shockingly, 1 in 6 Americans falls ill from contaminated food or beverages annually, leading to a staggering 3,000 deaths. The financial ramifications, quantified by the U.S. Department of Agriculture (USDA) at over USD 15.6 billion each year, underscore the magnitude of this issue.

In navigating this complex landscape, the market emerges as a crucial component in addressing the aftermath of foodborne illnesses. Recognized as a supportive measure, IV hydration therapy plays a pivotal role in managing dehydration, a common consequence associated with these illnesses. With its capability for efficient and swift fluid replenishment, intravenous hydration therapy becomes an invaluable asset within the healthcare response framework, actively contributing to mitigating the impact of foodborne illnesses on the well-being of individuals.

 Request a free sample copy or view report summary: North America IV Hydration Therapy Market Report

North America IV Hydration Therapy Market Report Highlights

• The energy boosters segment led the market with the largest revenue share of 25.4% in 2025, driven by rising consumer demand for quick fatigue relief, enhanced stamina, and stress management.

• The medicated segment led the market with the largest revenue share of 67.0% in 2025. This dominance is due to the increasing demand for medications administered through the IV route, along with key players focusing on developing customizable medicated IV hydration therapy solutions.

• The physical providers segment accounted for the largest market revenue share in 2025, driven by strong patient preference for in-clinic administration, direct medical supervision, and perceived safety and credibility.

• The hospitals & clinics segment accounted for the largest market revenue share in 2025. Segment growth can be attributed to their established clinical infrastructure, the availability of licensed healthcare professionals, and higher patient trust.

• U.S. dominated the North America IV hydration therapy market with the largest revenue share of 83.3% in 2025, driven by increasing awareness of the benefits of intravenous fluids for rapid rehydration, nutrient replenishment, and wellness applications.

North America IV Hydration Therapy Market Segmentation

Grand View Research has segmented the North America IV hydration therapy market on the basis of service, component, provider type, end use, and region:

North America IV Hydration Therapy Service Outlook (Revenue, USD Million, 2021 - 2033)

• Immune Boosters

• Energy Boosters

• Hydration

• Beauty/ Aesthetics

• Detoxification

• Longevity/ Antiaging

• Performance/ Athletics

• Migraine & Pain Relief

• Stress/Sleep/Mood Support

• Flu/Stomach

• Others

North America IV Hydration Therapy Component Outlook (Revenue, USD Million, 2021 - 2033)

• Medicated

• Non-medicated

North America IV Hydration Therapy Provider Type Outlook (Revenue, USD Million, 2021 - 2033)

• Mobile Providers

• Physical Providers

North America IV Hydration Therapy End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals & Clinics

• Wellness Centers and Spas

• Home Healthcare

• Others

North America IV Hydration Therapy Country Outlook (Revenue, USD Million, 2021 - 2033)

• U.S.

• Canada

• Mexico

List of Key Players in the North America IV Hydration Therapy Market

• Baxter

• B. Braun SE

• Otsuka Pharmaceutical Co., Ltd.

• Grifols, S.A.

• Vifor Pharma Management Ltd.

• JW Life Science Corporation

• Amanta Healthcare

• NexGen Health

• Core IV Therapy, LLC

• Drip Hydration

• REVIV

• Drip Hydration

• DriPros IV Hydration Wellness

• wHydrate

• Renew Ketamine & Wellness Center

• R2 Medical Clinic

• AliveDrip

• Hydrate IV

• Hydration Room